BioXcel Therapeutics (BTAI) Reports Q1 Loss of $1.08/sh

BioXcel Therapeutics (NASDAQ: BTAI) reported Q1 EPS of ($1.08), versus ($0.79) reported last year.

For earnings history and earnings-related data on BioXcel Therapeutics (BTAI) click here.

You May Also Be Interested In

• EU proposes to curb Airbnb and short-term rentals amid housing shortage
• UBS Upgrades E.ON SE (EOAN:GR) (EONGY) to Buy
• Computacenter Plc. (CCC:LN) PT Raised to GBP60 at JPMorgan